GT Grossberg, Manes F, RF Allegri, et al..  The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors. CNS spectrums 2013 27: 469-78

The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors.

Ibanez A, Aguado J, Báez S, Huepe D, R Ortega, Sigman M, Mikulan E, Lischinsky A, Torrente F, Cetkovich M, Torralva T, Bekinschtein T, Manes F.  From neural signatures of emotional modulation to social cognition: Individual differences in healthy volunteers and psychiatric participants. Social Cognitive and Affective Neurosciences 2013 9:939-50

From neural signatures of emotional modulation to social cognition: Individual differences in healthy volunteers and psychiatric participants.